(Q46069251)

English

Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

0 references

author name string

Gerrit Borchard

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

Beat Flühmann

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

Stefan Mühlebach

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

language of work or name

0 references

publication date

23 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

Regulatory Toxicology and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

64

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

324-328

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Non-transferrin bound iron: a key role in iron overload and iron toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Iron uptake and metabolism in the new millennium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Physicochemical and toxicological characterization of a new generic iron sucrose preparation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Do two intravenous iron sucrose preparations have the same efficacy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

The therapeutic equivalence of complex drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Diagnosis and management of iron deficiency anemia in patients with IBD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Use of parenteral iron products and serious anaphylactic-type reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.08.009

7 January 2021

Identifiers

10.1016/J.YRTPH.2012.08.009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22951348

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46069251&oldid=2090597045"